Dipeptidyl peptidase IV is a target for covalent adduct formation with the acyl glucuronide metabolite of the anti-inflammatory drug zomepirac

The nonsteroidal anti-inflammatory drug zomepirac (ZP) is metabolised to a chemically reactive acyl glucuronide conjugate (ZAG) which can form covalent adducts with proteins. In vivo, such adducts could initiate immune or toxic responses. In rats given ZP, the major band detected in liver homogenates by immunoblotting with a polyclonal ZP antiserum was at 110 kDa. This adduct was identified as ZP-modified dipeptidyl peptidase IV (DPP IV) by immunoblotting using the polyclonal ZP antiserum and monoclonal DPP IV antibodies OX-61 and 236.3. In vitro, ZAG, but not ZP itself, covalently modified recombinant human and rat DPP IV. Both monoclonal antibodies recognized DPP IV in livers from ZP- and vehicle-dosed rats. Confirmation that the 110 kDa bands which were immunoreactive with the ZP and DPP IV antibodies represented the same molecule was obtained from a rat liver extract reciprocally immunodepleted of antigens reactive with these two antibodies. Furthermore, immunoprecipitations with OX-61 antibody followed by immunolotting with ZP antiserum, and the reciprocal experiment, showed that both these antibodies recognised the same 110 kDa molecule in extracts of ZP-dosed rat liver. The results verify that DPP IV is one of the protein targets for covalent modification during hepatic transport and biliary excretion of ZAG in rats. (C) 2001 Elsevier Science Inc. All rights reserved.

Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis

We report our experience with the combination of anti-thymocyte globulin (ATGAM) and tacrolimus in the treatment of 20 patients with steroid refractory and dependent acute graft-versus-host disease (GVHD) transplanted between August 1996 and February 2000. All patients received cyclosporine-based GVHD prophylaxis. Thirteen patients developed a maximum of grade TV, five grade III and two grade II acute GVHD, with 15 patients being refractory to steroids and five dependent on steroids. Patients were treated with ATGAM (15 mg/kg for 5 d) and tacrolimus (0.025-0.1 mg/kg/d) in addition to continuation of their high-dose steroids and cessation of their cyclosporine. Within 28 d of treatment, we observed eight complete responses (CR), six partial responses (PR) and six with no response. Overall response (CR + PR) was predicted by GVHD severity. Infectious complications occurred in 80% of patients. The median survival was 86.5 d (range, 21-1081 d) with 35% of patients remaining alive, Survival following combination therapy was significantly more likely in men (P < 0.001), skin-only GVHD (P = 0.027), less severe GVHD (P = 0.048), and in responders to tacrolimus and ATGAM (P< 0.001). In conclusion, concurrent introduction of ATGAM and tacrolimus is a promising therapeutic combination for GVHD refractory to steroids and cyclosporine.

Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity

Polynucleotide immunisation with the E7 gene of human papillomavirus (HPV) type 16 induces only moderate levels of immune response, which may in part be due to limitation in E7 gene expression influenced by biased HPV codon usage. Here we compare for expression and immunogenicity polynucleotide expression plasmids encoding wild-type (pWE7) or synthetic codon optimised (pHE7) HPV16 E7 DNA. Cos-1 cells transfected with pHE7 expressed higher levels of E7 protein than similar cells transfected with pW7. C57BL/6 mice and F1 (C57X FVB) E7 transgenic mice immunised intradermally with E7 plasmids produced high levels of anti-E7 antibody. pHE7 induced a significantly stronger E7-specific cytotoxic T-lymphocyte response than pWE7 and 100% tumour protection in C57BL/6 mice, but neither vaccine induced CTL in partially E7 tolerant K14E7 transgenic mice. The data indicate that immunogenicity of an E7 polynucleotide vaccine can be enhanced by codon modification. However, this may be insufficient for priming E7 responses in animals with split tolerance to E7 as a consequence of expression of E7 in somatic cells. (C) 2002 Elsevier Science (USA).

Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomide

Objective To report on the failure of thalidomide to inhibit tumour growth in an animal model of human renal cell carcinoma (RCC). Materials and methods An orthotopic xenograft model of human RCC was used in which tumour cells were implanted in the left kidney of male 'severe combined immunodeficient' mice. Thalidomide was administered by intraperitoneal injection and after 34 days the mice were killed. The extent of tumour growth was compared in treated and untreated mice. Total RNA was extracted from both tumour-affected and contralateral kidneys, and analysed by reverse transcription-polymerase chain reaction for various genes implicated in angiogenesis and metastasis in RCC. Results Thalidomide failed to inhibit the growth of xenograft tumours. The expression of angiogenic genes, e.g. vascular endothelial growth factor and fibroblast growth factor type 2 (FGF-2) within normal and tumour-affected kidney tissue was not reduced by thalidomide. Intratumoral transcription Of beta(3)-integrin, a critical component of angiogenesis, was significantly increased in response to thalidomide treatment (P

The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine

NOR-1/NR4A3 is an orphan member of the nuclear hormone receptor superfamily. NOR-1 and its close relatives Nurr1 and Nur77 are members of the NR4A subgroup of nuclear receptors. Members of the NR4A subgroup are induced through multiple signal transduction pathways. They have been implicated in cell proliferation, differentiation, T-cell apoptosis, chondrosarcomas, neurological disorders, inflammation, and atherogenesis. However, the mechanism of transcriptional activation, coactivator recruitment, and agonist-mediated activation remain obscure. Hence, we examined the molecular basis of NOR-1-mediated activation. We observed that NOR-1 trans-activates gene expression in a cell- and target-specific manner; moreover, it operates in an activation function (AF)-1-dependent manner. The N-terminal AF-1 domain delimited to between amino acids 1 and 112, preferentially recruits the steroid receptor coactivator (SRC). Furthermore, SRC-2 modulates the activity of the AF-1 domain but not the C-terminal ligand binding domain (LBD). Homology modeling indicated that the NOR-1 LBD was substantially different from that of hRORbeta, a closely related AF-2-dependent receptor. In particular, the hydrophobic cleft characteristic of nuclear receptors was replaced with a very hydrophilic surface with a distinct topology. This observation may account for the inability of this nuclear receptor LBD to efficiently mediate cofactor recruitment and transcriptional activation. In contrast, the N-terminal AF-1 is necessary for cofactor recruitment and can independently conscript coactivators. Finally, we demonstrate that the purine anti-metabolite 6-mercaptopurine, a widely used antineoplastic and anti-inflammatory drug, activates NOR-1 in an AF-1-dependent manner. Additional 6-mercaptopurine analogs all efficiently activated NOR-1, suggesting that the signaling pathways that modulate proliferation via inhibition of de novo purine and/or nucleic acid biosynthesis are involved in the regulation NR4A activity. We hypothesize that the NR4A subgroup mediates the genotoxic stress response and suggest that this subgroup may function as sensors that respond to genotoxicity.

Resistência natural da madeira de sete espécies de eucalipto ao apodrecimento

A resistência natural ao apodrecimento se constitui numa importante propriedade da madeira. Em se tratando das madeiras provenientes do gênero Eucalyptus, tal atributo se torna ainda mais importante, uma vez que tais madeiras são, na grande maioria das vezes, de difícil tratabilidade pelos métodos de tratamento convencionais. O objetivo do presente trabalho foi determinar a resistência natural da madeira de sete espécies de eucalipto em ensaio acelerado de laboratório ao fungo causador da podridão-parda Gloeophyllum trabeum. Foram ensaiadas madeiras das espécies de Corymbia citriodora, Eucalyptus tereticornis, E. paniculata, E. pilularis, E. cloeziana, E. urophylla e E. grandis com 16 anos de idade, que cresceram na Estação Experimental de Anhembi, em São Paulo, pertencente ao Departamento de Ciências Florestais da ESALQ/USP. No que diz respeito ao apodrecimento causado pelo fungo Gloeophyllum trabeum, a madeira de eucalipto das sete espécies pode ser considerada resistente, uma vez que os valores de perda de massa foram sempre inferiores a 10%.

Influência dos estrativos na resistência ao apodrecimento de seis espécies de madeira

O presente trabalho teve como objetivo avaliar o efeito da extração da madeira de seis espécies, quatro nativas (candeia, cedro, cerejeira e jacarandá-caviúna) e duas exóticas (E. citriodora e E. gumifera), em diferentes solventes, na resistência ao apodrecimento causado pelo fungo da podridão-parda Gloeophyllum trabeum. O material foi ensaiado na forma de serragem, em face da maior facilidade para os procedimentos de extração. Dentre os resultados, pode-se destacar a baixa perda de massa ocorrida na madeira de cedro (Cedrela fissilis), evidenciando sua elevada resistência natural ao fungo testado e, ainda, à incapacidade dos solventes utilizados na retirada de compostos que conferem resistência ao apodrecimento. As madeiras de candeia (Vanillosmopsis erythropappa), cerejeira (Amburana cearensis), jacarandá-caviúna (Machaerium scleroxylon) e de eucaliptos (Corymbia citriodora e Eucalyptus gummifera) também apresentaram elevada resistência natural, em função da baixa perda de massa ocorrida, quando expostas ao fungo G. trabeum. Essas madeiras, quando totalmente extraídas, apresentaram elevados valores de perda de massa. No que diz respeito ao material extraído por diferentes solventes de forma isolada, observou-se, na candeia, que o solvente mais eficiente na retirada de substâncias que conferem resistência ao apodrecimento foi o diclorometano. Com relação ao cedro, o mais eficiente foi o metanol. Na cerejeira, por meio da mistura de etanol/tolueno retiraram-se mais substâncias, ao passo que no jacarandá-caviúna foi o metanol. Nas madeiras de eucaliptos, o metanol foi mais eficiente na retirada de componentes tóxicos ao fungo utilizado neste estudo, devendo destacar ainda, no E. gummifera, a eficiência da água quente na retirada de tais compostos. No C. citriodora, os valores de perda de massa, em razão das extrações em água fria, em água quente, em diclorometano e ao natural (não-extraída), foram muito baixos.